• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Healthcare Reform

How conversations with virtual people could help mitigate the opioid crisis

January 25, 2018 By Sarah Faulkner

It often starts in the doctor’s office or the emergency room. A patient has broken their leg and will be in pain for weeks. Another patient has had back surgery and is on their way home, but it will take time before they’re fully recovered. A third patient has returned for a consult about the […]

Filed Under: Healthcare Reform, Hospital Care, Pain Management, Pharmaceutical Tagged With: kognito

Senate confirms former pharma exec Azar as Trump’s HHS chief

January 24, 2018 By Sarah Faulkner

The Senate voted 55-43 today to approve president Donald Trump’s nominee for chief of the Dept. of Health and Human Services, Alex Azar. Azar is succeeding Tom Price, who was forced out after reports from Politico revealed he often used pricey charter jets on the taxpayer’s dime. Senate Republicans have argued that Azar, who previously worked as president of Eli […]

Filed Under: Healthcare Reform, Hospital Care, Pharmaceutical Tagged With: AdvaMed

Senate panel approves HHS nominee Azar

January 18, 2018 By Sarah Faulkner

The Senate finance committee has approved president Donald Trump’s nominee for chief of the Dept. of Health and Human Services, Alex Azar. The former drug company executive is expected to be confirmed by the full Senate. If confirmed, Azar will succeed Tom Price, who was forced out after reports from Politico revealed he often used pricey charter […]

Filed Under: Healthcare Reform, Pharmaceutical, Wall Street Beat Tagged With: Eli Lilly & Co., U.S. Department of Health and Human Services

Rebelling against high prices, hospitals form nonprofit generic drug company

January 18, 2018 By Sarah Faulkner

A consortium made up of 300 hospitals – and counting – are taking a bold step to address high drug prices and shortages of essential medicines: they’re cutting out the pharma middleman and starting their own non-profit generic drug company. The move is a first of its kind, according to a report from The New York […]

Filed Under: Healthcare Reform, Hospital Care, Pharmaceutical, Wall Street Beat

Is tax reform good or bad for medical device companies?

January 17, 2018 By Chris Newmarker

Medical device companies and others in the healthcare sector stand to benefit from the tax reform Congress passed at the end of 2017, but the picture isn’t entirely rosy, according to a new report from S&P Global Ratings. In many ways, the report offers a corrective to the bullish statements coming from corporate CEOs such […]

Filed Under: Business/Financial News, Healthcare Reform, News Well, Wall Street Beat Tagged With: Abbott, Baxter, BD, Dentsply Sirona, Hillrom, Johnson and Johnson, medicaldevicetax, Medtronic, Owens and Minor

At confirmation hearing for Trump’s HHS nominee, drug pricing takes center-stage

January 10, 2018 By Sarah Faulkner

Alex Azar, the president’s nominee to head the Dept. of Health & Human Services, has nearly a decade of experience in the pharmaceutical industry – and that experience is either predictive of his inability to act on lowering drug prices or will serve him well as HHS chief, depending on who you ask. At Azar’s […]

Filed Under: Diabetes, Healthcare Reform, Pharmaceutical, Wall Street Beat Tagged With: Eli Lilly & Co.

7 top stories that mattered for medtech in 2017

December 21, 2017 By Chris Newmarker

The medtech industry saw its transformation accelerate in 2017: Whether it’s the roster of largest companies, business models or the regulatory environment, times are a-changing. Competition is also heating up in areas including diabetes care and robotic surgery. Here are seven stories that mattered for the medical device industry this year. Next>>

Filed Under: Business/Financial News, Diabetes, Food & Drug Administration (FDA), Healthcare Reform, Mergers & Acquisitions, Regulatory/Compliance, Robotics Tagged With: Abbott, Bigfoot Biomedical, Cardinal Health, FDA, Hurricane Maria, Johnson and Johnson, medicaldevicetax, Medtronic, value-based healthcare

Report: Drugmakers may have ducked $1.3B in Medicaid rebates

December 21, 2017 By Sarah Faulkner

Without calling out any drug companies by name, the U.S. Dept. of Health and Human Services’ Office of Inspector General revealed this week that 10 potentially misclassified drugs may have resulted in $1.3 billion in lost rebates to Medicaid between 2012 and 2016. The issue of ducking rebates came to the public’s attention earlier this […]

Filed Under: Drug-Device Combinations, Healthcare Reform, Pharmaceutical, Wall Street Beat Tagged With: Centers for Medicare and Medicaid Services (CMS), Mylan

US House proposes 5-year extension to medical device tax suspension

December 12, 2017 By Fink Densford

The US House of Representatives has proposed a five-year suspension to the medical device tax that would keep it from becoming active again next year, according to an AdvaMed press release posted today. The proposal comes from House Ways & Means Committee Chair Kevin Brady (R-Texas) and Reps. Erik Paulsen (R-Minn.) and Jackie Walorski (R-Ind.), […]

Filed Under: Business/Financial News, Healthcare Reform Tagged With: Capitol Hill

Is medtech behind the curve on value-based care?

December 4, 2017 By Chris Newmarker

Less than 60% of healthcare professionals think medical device brands meet their patient outcomes expectations – an important part of value-based care, according to a new survey from analytics platform company Vennli. “With the changes occurring in value-based healthcare model, healthcare providers are subject to more scrutiny than ever before. … Providers will put pressure on […]

Filed Under: Business/Financial News, Healthcare Reform, Medicare, News Well Tagged With: value-based healthcare, vennli

CVS Health to buy Aetna in $69B merger

December 4, 2017 By Sarah Faulkner

CVS Health (NYSE:CVS) plans to buy health insurer Aetna (NYSE:AET) in a $69 billion merger, according to a report from The New York Times. The deal comes as companies like Amazon (NSDQ:AMZN), which is reportedly trying to launch into the pharmacy business, are looking to change the way that consumers interact with the healthcare industry. Get the full story at our sister […]

Filed Under: Healthcare Reform, Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: Aetna, Amazon, CVS Health

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 74
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS